Exane Derivatives Sol Gel Technologies Ltd. Transaction History

Exane Derivatives

  • $157 Million
  • Q2 2022

A detailed history of Exane Derivatives transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Exane Derivatives holds 61 shares of SLGL stock, worth $1,823. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Previous 61 -0.0%
Holding current value
$1,823
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 28, 2021
BUY
$9.53 - $14.7 $581 - $896
61 New
61 $0

Others Institutions Holding SLGL

# of Institutions
4
Shares Held
123K
Call Options Held
0
Put Options Held
0
View Full List

About Sol-Gel Technologies Ltd.

SLGL Quotes by TradingView
  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $692M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email